Trials / Unknown
UnknownNCT02699528
The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder
Does Methylphenidate, Prescribed for Attention Deficit Disorder, Influence Primary Enuresis in These Children?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Meir Medical Center · Academic / Other
- Sex
- All
- Age
- 5 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
To assess wether methylphenidate reduces the prevalence of primary nocturnal enuresis in children with attention deficit disorder
Detailed description
Children aged 5 - 10 years newly diagnosed with attention deficit hyperactivity disorder who report primary nocturnal enuresis, Investigators will obtain baseline data (from parents/caregivers) on their sleep habits and enuresis characteristics by questionnaire. After 6 weeks of methylphenidate therapy, prescribed for the attention deficit, a new questionnaire will be filled.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | methylphenidate | The drug will be prescribed as indicated for attention deficit disorder |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-04-01
- Completion
- 2017-05-01
- First posted
- 2016-03-04
- Last updated
- 2016-09-16
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02699528. Inclusion in this directory is not an endorsement.